Skip to main content
OpenTrials

Clinical trial condition

Acute Lymphoblastic Leukemia, in Relapse

Explore clinical trials studying Acute Lymphoblastic Leukemia, in Relapse. Study availability and eligibility vary by location and protocol.

26 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Acute Lymphoblastic Leukemia, in Relapse trial results

Recruiting

HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies

NCT05658640

Conditions
Acute Lymphoblastic Leukemia, in Relapse, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • St. Anna Kinderspital Vienna, Austria
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • Rigshospitalet Copenhagen Copenhagen, Denmark
  • Helsinki University Hospital, New Children's Hospital Helsinki, Finland
View all 36 locations
View Trial Details
Recruiting

CD19/CD22 CAR-T Cells in Adults With R/R ALL or NHL

NCT06445803

Conditions
Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia, in Relapse, B-cell Lymphoma Recurrent, +12 more
Locations
  • The First Affiliated Hospital of Nanchang University; Nanchang, Jiangxi, China
  • Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
View Trial Details

Related conditions